Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Chemical Science|May 30, 2025
Synthesis of polysubstituted cyclobutanes through a photoredox strain-release/[3,3]-rearrangement cascadeFangqing Zhang, Chun Xu, Zichun Zhang, et al.Organic Letters|May 10, 2018
Stereoselective Total Synthesis of (±)-5- epi-Cyanthiwigin I via an Intramolecular Pauson-Khand Reaction as the Key StepYuanyuan Chang, Linlin Shi, Jun Huang, et al.Life (Basel, Switzerland)|March 28, 2026
Quercetin Attenuates Iron Overload-Induced Renal Injury via Activating Nrf2/xCT/GPX4 Signaling to Inhibit FerroptosisXiaoyi Wang, Wenmi Li, Wenzheng Yuan, et al.International Journal of Biological Macromolecules|December 8, 2024
Co-immunization with IFI35 enhances the therapeutic effect of an adenovirus vaccine against renal carcinomaBowen Lu, Leizi Chai, Zichun Zhang, et al.Journal of Cellular and Molecular Medicine|July 30, 2020
Absent in melanoma 2 enhances anti-tumour effects of CAIX promotor controlled conditionally replicative adenovirus in renal cancerDafei Chai, Dong Qiu, Zichun Zhang, et al.Molecular Therapy Oncolytics|January 3, 2022
Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunityDafei Chai, Dong Qiu, Xiaoqing Shi, et al.Human Vaccines & Immunotherapeutics|September 14, 2021
Using PAMPs and DAMPs as adjuvants in cancer vaccinesHuanyou Sun, Wenwen Hu, Yinan Yan, et al.Cancers|June 24, 2022
IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent AutophagyDafei Chai, Shang Yuchen Shi, Navid Sobhani, et al.Translational Oncology|January 25, 2021
Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinomaDafei Chai, Zichun Zhang, Shang Yuchen Shi, et al.Discover Oncology|June 6, 2026
Integrating multi-omics and clinical management in breast cancer: a comprehensive reviewXiangxiang Cao, Yunchang Yang, Pengbo Wang, et al.Pageof 4